Story
Vera Therapeutics Options See Large Bullish Bet on September Rally

A significant and unusual surge in options activity for Vera Therapeutics (NASDAQ: VERA) on Tuesday was highlighted by a massive trade betting on the stock's appreciation by next month's expiration. The volume suggests an institutional player has established a large, risk-defined bullish position.
The Trade in Detail
Total options volume in Vera Therapeutics soared to 13,224 contracts, a stark increase over its typical activity. The trading was overwhelmingly bullish, with call options accounting for 12,811 contracts versus just 413 for puts.
The centerpiece of the session's activity was a large bullish call spread. The trade involved:
- Buying 6,022 contracts of the September $35 strike calls.
- Simultaneously selling 6,022 contracts of the September $45 strike calls.
This strategy, known as a bullish call spread, is profitable if VERA's stock price closes above the $35 strike price by the September 18 expiration. The trade's maximum profit is realized if the stock is at or above $45, while selling the higher-strike call serves to reduce the initial cost of the position.
What the Data Suggests
AdThe sheer size of the transaction points toward an institutional investor rather than retail traders. A significant increase in open interest for both the $35 and $45 call strikes confirms that this was a new position being established, reinforcing the directional nature of the bet.
Despite the bullish trade, market indicators of future price swings have moderated slightly. According to market data, three-month implied volatility fell to 71.99%. While still elevated, the decline suggests expectations for wild price swings may be cooling. This aligns with the structure of a call spread, which profits from a controlled rally rather than an explosive, open-ended surge.
Context for Investors
This options activity represents a vote of confidence in a near-term rally for Vera Therapeutics, though with defined limits. The trader is targeting a move above $35 but appears to see resistance or is willing to cap gains around the $45 level.
This position appears relatively conservative when compared to Wall Street analyst targets, which average $77.14, according to Investing.com. The trade could be a reaction to recent company news or a strategic play ahead of potential catalysts. For market watchers, the key level to watch will be whether VERA's stock can sustain a price above $35 as the September expiration approaches.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.